Coherus to Report First Quarter 2024 Financial Results on May 9, 2024

About this update from Coherus Oncology, Inc.

REDWOOD CITY, Calif. , May 01, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences , Inc. (“Coherus,” NASDAQ: CHRS) today announced that its first quarter 2024 financial results will be released after market close on Thursday, May 9, 2024 . Starting at 5:00 p.m. EDT on May 9, 2024 , Coherus’ management team will host a conference call and webcast to discuss financial results and provide a general business update. A webcast replay will be available on https://investors.coherus.com following the conclusion of the live conference call. Conference Call Information When: Thursday, May 9, 2024 , starting at 5:00 p.m. Eastern Daylight Time To access the conference call:Dial: (800) 715-9871 (toll-free USA and Canada ); (646) 307-1963 (international)Conference ID: 4442005 Webcast: https://edge.media-server.com/mmc/p/jqq7phbt/ The press release with the first quarter 2024 financial results and related materials will be available at https://investors.coherus.com before the start of the conference call. A live and archived webcast will be available on the “Investors” section of the Coherus website at https://investors.coherus.com/events-presentations . Please dial in 15 minutes early to ensure a timely connection to the call. Disclosure Information Coherus uses the https://investors.coherus.com website as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. Coherus Contact Information Investors: Jami Taylor , Head of Investor Relations for Coherus [email protected] Source: Coherus BioSciences, Inc.

View stock analysis, news, and events for Coherus Oncology, Inc.